Medical aid to die: Canadians invited to speak

News 16 December, 2017
  • Photo Fotolia

    QMI agency

    Saturday, 16 December 2017 16:17

    UPDATE
    Saturday, 16 December 2017 16:17

    Look at this article

    OTTAWA | government of Canada invites Canadians to comment on the draft regulation on the monitoring of the medical assistance to die.

    Ottawa has recalled Saturday that the Law on medical assistance to die, which was adopted in June 2016, authorized a regulation on the monitoring of the performance of aid in dying in Canada as well as the implementation report in this regard is proposed.

    “The publication of such reports is essential to ensure transparency and maintain the confidence of the public”, says one.

    In this regard, a draft regulation has been published Saturday by the government of Canada, “a measure essential to the creation of a federal system-wide follow-up of medical help to die,” said the ministry in a press release.

    Until the 13th of next February, Canadians and stakeholders are invited to review the draft regulations and their comments.

    The final regulation should enter into force by next summer.

    From there, the federal ministry of Health produces annual reports to Canadians in the context of this new monitoring system by 2019.

    “I know that medical help to die is a very personal issue for all Canadians. The government recognizes that they wish to have access to the options of end-of-life that reflect their preferences and their personal values. We have worked with provinces, territories and key stakeholders to develop a uniform approach to the implementation of reports on medical assistance to die, and we will be happy to receive the comments of Canadians on the proposed regulations,” said the minister of Health, Ginette Petitpas Taylor.

    Until the entry into force of the regulation, Ottawa will work with the provinces and territories for the publication, every six months, interim reports.

    The annual reports on medical aid to die (AMM) should contain:

    • A statistical profile of deaths attributable to the marketing authorisation in Canada, including the number of requests and the results of recent
    • Information on the medical circumstances and other general characteristics of individuals requesting and receiving the AMM
    • The findings regarding the application of eligibility criteria and safeguard measures
    • Information on the trends that emerge as multi-year data become available)

    These reports will contain aggregate information that does not identify anyone

    Source: Health Canada